Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice
暂无分享,去创建一个
Weibin Song | Hong D. Chen | Mei Duan | Jiangli Dong | Tao Wang | Xin Li | Haotian Feng
[1] Nick Andrews,et al. The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation. , 2016, Vaccine.
[2] T. Vesikari,et al. Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine , 2015, Human vaccines & immunotherapeutics.
[3] H. Daniell,et al. Plant-made oral vaccines against human infectious diseases-Are we there yet? , 2015, Plant biotechnology journal.
[4] F. Takaiwa,et al. Rice seed for delivery of vaccines to gut mucosal immune tissues. , 2015, Plant biotechnology journal.
[5] S. Streatfield,et al. Plant‐produced candidate countermeasures against emerging and reemerging infections and bioterror agents , 2015, Plant biotechnology journal.
[6] C. Yung,et al. Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study. , 2015, The Journal of pediatrics.
[7] S. Marashi,et al. Rotavirus VP6 preparations as a non-replicating vaccine candidates. , 2015, Vaccine.
[8] S. Escolano,et al. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach. , 2015, Vaccine.
[9] Kan Wang,et al. Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice , 2015, Plant Cell Reports.
[10] M. Papi,et al. Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein , 2014, International journal of nanomedicine.
[11] F. Esquivel-Guadarrama,et al. The assembly conformation of rotavirus VP6 determines its protective efficacy against rotavirus challenge in mice. , 2014, Vaccine.
[12] R. Glass,et al. Rotavirus vaccines , 2014, Human vaccines & immunotherapeutics.
[13] Juan Pablo Peña-Rosas,et al. Global maize production, utilization, and consumption , 2014, Annals of the New York Academy of Sciences.
[14] N. B. da Cunha,et al. Molecular farming of human cytokines and blood products from plants: Challenges in biosynthesis and detection of plant‐produced recombinant proteins , 2014, Biotechnology journal.
[15] M. Oyama,et al. Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. , 2013, The Journal of clinical investigation.
[16] Jingjuan Yu,et al. Improved Nutritive Quality and Salt Resistance in Transgenic Maize by Simultaneously Overexpression of a Natural Lysine-Rich Protein Gene, SBgLR, and an ERF Transcription Factor Gene, TSRF1 , 2013, International journal of molecular sciences.
[17] T. Nashar,et al. E. coli Heat-labile Enterotoxin B Subunit as a Platform for the Delivery of HIV Gag p24 Antigen , 2013, Journal of clinical & cellular immunology.
[18] Fu Jin-na. E. coli Heat-labile Enterotoxin B Subunit Secretory Expression in Lactobacillus Casei , 2013 .
[19] Celine A. Hayden,et al. Production of highly concentrated, heat-stable hepatitis B surface antigen in maize. , 2012, Plant biotechnology journal.
[20] M. Gómez-Lim,et al. Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein. , 2012, Vaccine.
[21] M. Estes,et al. Rotavirus non-structural proteins: structure and function. , 2012, Current opinion in virology.
[22] Javier Martin,et al. Investigation of porcine circovirus contamination in human vaccines. , 2012, Biologicals : journal of the International Association of Biological Standardization.
[23] E. Lentz,et al. VP8* antigen produced in tobacco transplastomic plants confers protection against bovine rotavirus infection in a suckling mouse model. , 2011, Journal of biotechnology.
[24] J. Cunnick,et al. Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler’s diarrhea , 2011, Plant Cell Reports.
[25] P. Krause,et al. Molecular and infectivity studies of porcine circovirus in vaccines. , 2011, Vaccine.
[26] D. Doolan,et al. Non-toxic derivatives of LT as potent adjuvants. , 2011, Vaccine.
[27] N. Bannert,et al. Analysis of porcine circovirus type 1 detected in Rotarix vaccine. , 2011, Vaccine.
[28] Bin Wang,et al. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice. , 2010, Vaccine.
[29] Jiang Li,et al. Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides. , 2010, Plant biotechnology journal.
[30] N. Ajami,et al. Rotavirus enterotoxin NSP4 has mucosal adjuvant properties. , 2010, Vaccine.
[31] Manuel J T Carrondo,et al. Impact of physicochemical parameters on in vitro assembly and disassembly kinetics of recombinant triple‐layered rotavirus‐like particles , 2009, Biotechnology and bioengineering.
[32] S. Dasgupta,et al. Marker-free transgenic corn plant production through co-bombardment , 2009, Plant Cell Reports.
[33] X. Mao,et al. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. , 2009, Vaccine.
[34] H. Kajiura,et al. Generation of a transgenic rice seed-based edible vaccine against house dust mite allergy. , 2008, Biochemical and biophysical research communications.
[35] C. L. Armstrong,et al. Production of transgenic maize plants and progeny by bombardment of hi-II immature embryos , 1996, In Vitro Cellular & Developmental Biology - Plant.
[36] H. Kiyono,et al. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination , 2007, Proceedings of the National Academy of Sciences.
[37] H. Greenberg,et al. Rotavirus Anti-VP6 Secretory Immunoglobulin A Contributes to Protection via Intracellular Neutralization but Not via Immune Exclusion , 2006, Journal of Virology.
[38] M. Estes,et al. Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response. , 2006, Journal of biotechnology.
[39] M. Flores-Vergara,et al. A modified protocol for rapid DNA isolation from plant tissues using cetyltrimethylammonium bromide , 2006, Nature Protocols.
[40] G. Kang,et al. Evaluation of Serum Antibody Responses against the Rotavirus Nonstructural Protein NSP4 in Children after Rhesus Rotavirus Tetravalent Vaccination or Natural Infection , 2005, Clinical Diagnostic Laboratory Immunology.
[41] Yongsheng Jin,et al. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection. , 2005, Virology.
[42] J. A. Thomas,et al. Biopharmaceuticals derived from genetically modified plants. , 2004, QJM : monthly journal of the Association of Physicians.
[43] J. Gray,et al. The zoonotic potential of rotavirus. , 2004, The Journal of infection.
[44] M. Estes,et al. Emerging themes in rotavirus cell entry, genome organization, transcription and replication. , 2004, Virus research.
[45] Y. Jang,et al. Expression of the B Subunit of E. coli Heat-labile Enterotoxin in the Chloroplasts of Plants and its Characterization , 2003, Transgenic Research.
[46] J. Messing,et al. A homologous expression system for cloned zein genes , 1991, Theoretical and Applied Genetics.
[47] Wei Zhou,et al. Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA. , 2003, Virology.
[48] R. Bahl,et al. Rotavirus nonstructural protein NSP4 induces heterotypic antibody responses during natural infection in children. , 2003, The Journal of infectious diseases.
[49] B. Wiggins,et al. Delivery of subunit vaccines in maize seed , 2002, Journal of Controlled Release.
[50] B. Prasad,et al. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. , 2002, The Journal of clinical investigation.
[51] C. Arntzen,et al. Oral immunization with hepatitis B surface antigen expressed in transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[52] Jie Yu,et al. A plant-based multicomponent vaccine protects mice from enteric diseases , 2001, Nature Biotechnology.
[53] G. Corthier,et al. Bovine Rotavirus Nonstructural Protein 4 Produced by Lactococcus lactis Is Antigenic and Immunogenic , 2001, Applied and Environmental Microbiology.
[54] W. Kaniewski,et al. Isolation and Purification , 2001 .
[55] Pamela G. Guren,et al. Candidates , 1982, Otolaryngology–Head and Neck Surgery.
[56] R. Ward,et al. Antibody-Independent Protection against Rotavirus Infection of Mice Stimulated by Intranasal Immunization with Chimeric VP4 or VP6 Protein , 1999, Journal of Virology.
[57] H. Greenberg,et al. Immunity to rotavirus infection in mice. , 1999, The Journal of infectious diseases.
[58] H. Greenberg,et al. Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis. , 1997, Virology.
[59] M. Estes,et al. The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[60] G. García-Casado,et al. Role of complex asparagine-linked glycans in the allergenicity of plant glycoproteins. , 1996, Glycobiology.
[61] H. Greenberg,et al. Protective Effect of Rotavirus VP6-Specific IgA Monoclonal Antibodies That Lack Neutralizing Activity , 1996, Science.
[62] E. Kohli,et al. Epitope mapping of the major inner capsid protein of group A rotavirus using peptide synthesis. , 1993, Virology.
[63] D. M. Lam,et al. Expression of hepatitis B surface antigen in transgenic plants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[64] R. Schoner,et al. Isolation and purification of protein granules from Escherichia coli cells overproducing bovine growth hormone. 1985. , 1992, Biotechnology.
[65] J. T. Barr. What is the risk? , 1991, Risk analysis : an official publication of the Society for Risk Analysis.
[66] M. Fromm,et al. Factors Influencing Gene Delivery into Zea Mays Cells by High–Velocity Microprojectiles , 1988, Bio/Technology.
[67] M. Hunkapiller,et al. Purification of Microgram Quantities of Proteins by Polyacrylamide Gel Electrophoresis , 1986 .
[68] R. Schoner,et al. Isolation and Purification of Protein Granules from Escherichia coli Cells Overproducing Bovine Growth Hormone , 1985, Bio/Technology.